Sacubitril/valsartan use in a real-world population of patients with heart failure and reduced ejection fraction

M Mapelli, E Salvioni, F de Martino… - Journal of …, 2020 - journals.lww.com
Aims Practice guidelines recommend sacubitril/valsartan for heart failure with reduced
ejection fraction. The aim of our study was to describe the use of sacubitril/valsartan in real …

Sacubitril/valsartan use in a real-world population of patients with heart failure and reduced ejection fraction

M Mapelli, E Salvioni, F de Martino, I Mattavelli… - JOURNAL OF …, 2020 - air.unimi.it
Aims: Practice guidelines recommend sacubitril/valsartan for heart failure with reduced
ejection fraction. The aim of our study was to describe the use of sacubitril/valsartan in real …

Sacubitril/valsartan use in a real-world population of patients with heart failure and reduced ejection fraction

M Mapelli, E Salvioni, F de Martino… - Journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Aims Practice guidelines recommend sacubitril/valsartan for heart failure with reduced
ejection fraction. The aim of our study was to describe the use of sacubitril/valsartan in real …

Sacubitril/valsartan use in a real-world population of patients with heart failure and reduced ejection fraction.

M Mapelli, E Salvioni, F de Martino… - Journal of …, 2020 - europepmc.org
Aims Practice guidelines recommend sacubitril/valsartan for heart failure with reduced
ejection fraction. The aim of our study was to describe the use of sacubitril/valsartan in real …